Sk Biopharmaceuticals Co Ltd (326030) — Net Asset Momentum
Sk Biopharmaceuticals Co Ltd (326030) recorded a net asset momentum of 44.0% as of December 2025, with net assets of ₩826.27 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Sk Biopharmaceuticals Co Ltd net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Sk Biopharmaceuticals Co Ltd Net Asset Momentum (2016–2025)
This chart tracks Sk Biopharmaceuticals Co Ltd's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +44.0%, with net assets of ₩826.27 Billion KRW as of December 2025. For live market cap and overall valuation, see 326030 market cap.
Annual Net Asset History for Sk Biopharmaceuticals Co Ltd (2016–2025)
The table below shows the complete annual net asset history for Sk Biopharmaceuticals Co Ltd from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check 326030 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩826.27 Billion | ₩1.20 Trillion | ₩372.04 Billion | ▲ +44.0% |
| 2024 | ₩573.98 Billion | ₩1.04 Trillion | ₩462.83 Billion | ▲ +78.8% |
| 2023 | ₩320.95 Billion | ₩723.17 Billion | ₩402.22 Billion | ▲ +1.4% |
| 2022 | ₩316.56 Billion | ₩664.24 Billion | ₩347.68 Billion | ▼ -28.7% |
| 2021 | ₩444.19 Billion | ₩643.65 Billion | ₩199.46 Billion | ▲ +17.2% |
| 2020 | ₩379.07 Billion | ₩500.24 Billion | ₩121.17 Billion | ▲ +3010.2% |
| 2019 | ₩-13.03 Billion | ₩139.07 Billion | ₩152.10 Billion | ▼ -122.2% |
| 2018 | ₩58.63 Billion | ₩95.54 Billion | ₩36.91 Billion | ▲ +24.1% |
| 2017 | ₩47.24 Billion | ₩98.37 Billion | ₩51.12 Billion | ▼ -68.0% |
| 2016 | ₩147.69 Billion | ₩193.89 Billion | ₩46.21 Billion | — |